Last reviewed · How we verify

trypsin

unknown active ✓ Verified May 2026

trypsin is a drug. It is currently in unknown development.

Trypsin is a serine protease enzyme found in the digestive system of many vertebrates, where it breaks down proteins into smaller pieces through hydrolysis. It is primarily involved in cutting peptide chains at the carboxyl side of the amino acids lysine and arginine.

At a glance

Generic nametrypsin
Therapeutic areaOther
Phaseunknown

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about trypsin

What is trypsin?

trypsin is a pharmaceutical drug.

What development phase is trypsin in?

trypsin is in unknown.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing